糖尿病心肌病中的新兴:治疗干预的分子途径和目标
Mansi Vinodkumar Trivedi1, Hemant R Jadhav1, Anil Bhanudas Gaikwad1
1Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, India.
Drug development research
|November 3, 2025
概括
糖尿病心肌病 (DCM) 需要新的治疗方法. 本综述探讨了新的分子标和基于RNA的疗法,包括PANoptosis,cuproptosis和ferroptosis,以对抗DCM.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病心肌病 (DCM) 是糖尿病的一种严重并发症,缺乏有效的预防和治疗策略.
- 目前DCM的治疗方法有限,需要新的方法.
- 了解DCM背后的分子机制对于开发新干预措施至关重要.
研究的目的:
- 审查糖尿病心肌病的病理标志的新兴分子标.
- 探索新的基于RNA的治疗策略来管理DCM.
- 讨论这些目标在DCM药物发现中的潜力.
主要方法:
- 对DCM分子标和RNA治疗方法的研究进行了全面的文献综述.
- 分析DCM涉及的途径,包括纤维化,炎症,亡 (PANoptosis,cuproptosis,ferroptosis) 和线粒体功能障碍.
- 特定分子标的识别和讨论,如PDE4D,LGR6,IFI16,GDF11,TFEB,SFRP1,FGF21,TGR5,NR4A3,EZH2,piR112710和TUG1.1,这些分子标的识别和讨论.
主要成果:
- 几种分子标在抑制心肌纤维化等DCM特征和调节炎症和亡途径方面表现有前途.
- 特别的基化酶4D (PDE4D) 和转录因子EB (TFEB) 等特定标因其潜在的治疗作用而被强调.
- 基于RNA的疗法,包括piR112710和TUG1,为打击DCM进展提供了替代策略.
结论:
- 新型分子标和基于RNA的治疗方法为未来糖尿病心肌病药物发现提供了有希望的途径.
- 针对PANoptosis,cuproptosis,ferroptosis和线粒体功能障碍等途径可能导致有效的DCM干预.
- 对这些目标的进一步研究对于开发糖尿病心肌病的突破性治疗方法至关重要.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Coronary Artery Disease I: Introduction
868
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
868
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
Cardiomyopathy I: Introduction and Classification
490
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
490


